A5021458354- COVID-19 Clinical Research Studies
- Tuberculosis Research and Epidemiology
- COVID-19 epidemiological studies
- Drug Transport and Resistance Mechanisms
- SARS-CoV-2 and COVID-19 Research
- Liver Diseases and Immunity
- Liver Disease Diagnosis and Treatment
University of British Columbia
2025
King Faisal Specialist Hospital & Research Centre
2021-2022
King Abdulaziz Medical City
2022
Abstract Background Tuberculosis (TB) remains a significant global health threat. Upon diagnosis, patients with pulmonary TB are required to undergo specific isolation precautions prevent further disease transmission. Current practice typically mandates for at least two weeks post-diagnosis, extended periods those found have positive sputum acid fast bacilli (AFB) smear results. The most recent Canadian Standards (2022) and other international groups suggested that the decision discontinue...
The SARS-CoV-2 pandemic has led to a strain on medical resources. development of countermeasures prevent its spread is evolving. Healthcare workers (HCWs) are at high risk for contracting and transmitting the disease. Serology testing volunteer HCWs was performed King Faisal Specialist Hospital Research Center in Riyadh (the Center) order determine prevalence antibodies, as well associated factors, hope implementing adequate prevention control measures. 1076 subjects participated this study,...
Primary biliary cholangitis (PBC) is a progressive autoimmune cholestatic liver disease that primarily affects females more than males and may lead to end-stage disease. We studied baseline characteristics, the biochemical clinical response ursodeoxycholic acid (UDCA), first-line treatment option for patients with PBC, in cohort of diagnosed PBC from Saudi Arabia.A total 30 meeting diagnostic criteria who were being followed King Faisal Specialist Hospital Research Centre Riyadh, Arabia,...